May 2004
Volume 45, Issue 13
ARVO Annual Meeting Abstract  |   May 2004
Quantification of Enophthalmos
Author Affiliations & Notes
  • L. Koo
    Ophthalmology, Mass Eye and Ear Infirmary, Boston, MA
  • M.P. Hatton
    Ophthalmology, Mass Eye and Ear Infirmary, Boston, MA
  • P.A. D. Rubin
    Ophthalmology, Mass Eye and Ear Infirmary, Boston, MA
  • Footnotes
    Commercial Relationships  L. Koo, None; M.P. Hatton, None; P.A.D. Rubin, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 54. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Koo, M.P. Hatton, P.A. D. Rubin; Quantification of Enophthalmos . Invest. Ophthalmol. Vis. Sci. 2004;45(13):54.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The ability to detect enophthalmos may identify important clinical conditions, such as sinus disease, orbital fracture, and metastatic breast carcinoma. Little data exist regarding how many millimeters of enophthalmos must be present to be recognized in the clinical setting. Methods: The Massachusetts Eye and Ear Infirmary Oculoplastics and Orbital Surgery imaging database was used to select twelve photographs of patients with enophthalmos from 1 to 8 mm (by Hertel exophthalmometry) as the study group and 12 photographs of patients without enophthalmos as the control group. These photographs were uniformly cropped to include the brows, orbits, and nose in order to standardize the appearance of the photographs. Ophthalmologists, technicians, and support staff were asked to review each of the photographs and to comment on whether the person’s general appearance was "normal" or "abnormal". If they responded "abnormal" they were asked to describe why. Results: 87% of the control patients and 83% of patients with 1–2 mm enophthalmos were identified as "normal". 28% of patients with 3–4 mm enophthalmos were considered "normal" (p<0.001), and 3% of patients with 5–8 mm enophthalmos were considered "normal" (p<0.001). The three study groups were further subdivided. There was no statistical difference between the control, 1 mm, and 2 mm patients (87%, 80%, and 86% "normal" respectively). 42% of 3 mm patients were identified as "normal" (p<0.01). 14% of 4 mm patients were thought to be "normal" (p<0.001). There was a statistical difference between 2 mm vs. 3 mm of enophthalmos (p<0.05) and 3 mm vs. 4 mm (p<0.025). No statistical difference was noted between the patients with measurements of 5 mm and greater. Conclusions: Patients with 2 mm and less of enophthalmos appear as "normal" as control patients. Nearly all patients with 5mm and greater of enophthalmos appear "abnormal". About 40% of patients with 3 mm of enophthalmos were still considered "normal". These data indicate that the point at which enophthalmos becomes clinically detectable lies between 2 mm and 4 mm.

Keywords: orbit 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.